SETD7 and neoplasm: Si et al. analysed data from the Human Protein Atlas database and showed that SETD7 exhibited stronger positive expression in BC tissues when compared with normal breast, while mRNA expression data from the GEO database (GSE9893: 132 primary tumours from tamoxifen-treated patients; GSE12276: 204 primary tumours from patients with known site of relapse) revealed that SETD7 expression negatively impacts patient OS rates and local relapses, which is in agreement with their findings using the online Kaplan–Meier plotter [45].